ADAM 12 and PAPP-A at 14-17 weeks' gestation as biomarkers of pre-eclampsia.

D'Anna, R; Baviera, G; Giordano, D; Russo, S; Santamaria, A; Granese, R; Corrado, F

D'Anna, R; Baviera, G; Giordano, D; Russo, S; Santamaria, A; Granese, R; Corrado, F.

Prenat Diagn ; 31(6): 602-4, 2011 Jun.

Article in En | MEDLINE | ID: mdl-21413042

Subject(s)

ADAM Proteins/physiology; Biomarkers/blood; Membrane Proteins/physiology; Pre-Eclampsia/diagnosis; Pregnancy Trimester, First/blood; Pregnancy Trimester, Second/blood; Pregnancy-Associated Plasma Protein-A/physiology; ADAM Proteins/analysis; ADAM Proteins/blood; ADAM12 Protein; Adult; Biomarkers/analysis; Case-Control Studies; False Positive Reactions; Female; Humans; Membrane Proteins/analysis; Membrane Proteins/blood; Pre-Eclampsia/blood; Pregnancy; Pregnancy-Associated Plasma Protein-A/analysis; Prognosis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Pre-Eclampsia / Pregnancy-Associated Plasma Protein-A / Pregnancy Trimester, Second / Pregnancy Trimester, First / Biomarkers / ADAM Proteins / Membrane Proteins Type of study: Evaluation_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Pregnancy Language: En Journal: Prenat Diagn Year: 2011 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google